Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 274,272 | 300,119 | 234,285 | 278,598 | 310,407 |
| Receivables | 24,030 | 22,868 | 23,186 | 25,182 | 21,180 |
| Inventories | 16,072 | 15,191 | 15,997 | 16,177 | 22,728 |
| Other current assets | 18,631 | 17,181 | 16,738 | 5,990 | 21,283 |
| TOTAL | $333,005 | $355,359 | $290,206 | $336,291 | $375,598 |
| Non-Current Assets | |||||
| PPE Net | 5,721 | 5,483 | 5,785 | 5,622 | 5,260 |
| Investments And Advances | 0 | 260 | 930 | 1,647 | 26,989 |
| Intangibles | 0 | 0 | 0 | 0 | 12,358 |
| Other Non-Current Assets | 10,353 | 10,677 | 11,045 | 11,222 | 46,695 |
| TOTAL | $16,074 | $16,420 | $17,760 | $18,491 | $91,302 |
| Total Assets | $349,079 | $371,779 | $307,966 | $354,782 | $466,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 14,329 |
| Accounts payable and accrued liabilities | 14,372 | 10,708 | 14,315 | 15,569 | 8,977 |
| Accrued Expenses | 53,307 | 46,924 | 48,670 | 52,101 | N/A |
| Other current liabilities | N/A | N/A | N/A | N/A | 53,483 |
| TOTAL | $67,679 | $57,632 | $62,985 | $67,670 | $78,206 |
| Non-Current Liabilities | |||||
| Long Term Debt | 114,189 | 113,673 | 113,234 | 112,730 | 97,707 |
| Other Non-Current Liabilities | 339,157 | 332,144 | 326,196 | 322,631 | 345,168 |
| TOTAL | $453,346 | $445,817 | $439,430 | $435,361 | $442,875 |
| Total Liabilities | $521,025 | $503,449 | $502,415 | $503,031 | $521,081 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,690 | 96,647 | 82,814 | N/A | N/A |
| Common Shares | 8,233 | 8,233 | 7,312 | 7,312 | 7,312 |
| Retained earnings | -1,462,591 | -1,418,622 | -1,382,078 | -1,335,472 | -1,235,035 |
| Other shareholders' equity | -19 | -577 | 297 | 366 | 166,454 |
| TOTAL | $-171,946 | $-131,670 | $-194,449 | $-148,249 | $-54,181 |
| Total Liabilities And Equity | $349,079 | $371,779 | $307,966 | $354,782 | $466,900 |